Skip to content

KBYPF

KOBAYASHI PHARMACEUTICAL CO.,LTD.

化学 · 素材・化学 · JP

Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue166.8B165.7B165.6B173.5B166.3B
Cost of Revenue16.2B81.0B78.0B77.1B73.9B
Gross Profit17.4B84.7B87.6B96.4B92.3B
Operating Expenses
R&D Expense
SG&A Expense16.1B69.8B62.7B70.6B65.7B
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses16.1B69.8B62.7B70.6B65.7B
Cost and Expenses153.1B150.8B140.7B147.7B139.6B
Operating Income (EBIT)13.7B14.9B24.9B25.8B26.7B
Non-Operating
Interest Income137.0M335.0M207.0M214.0M85.0M
Interest Expense4.0M28.0M28.0M29.0M18.0M
Net Interest Income133.0M307.0M179.0M185.0M67.0M
Other Non-Op Income/Expense321.0M2.1B2.0B1.6B1.6B
Non-Operating Income (excl Interest)264.0M2.1B2.3B2.0B1.9B
EBT (Pre-Tax Income)1.7B3.7B13.9B27.6B27.9B
Income Tax Expense699.0M83.0M3.8B7.2B7.9B
Bottom Line
Net Income3.1B3.7B10.1B20.3B20.0B
Earnings from Cont. Ops
Earnings from Discont. Ops
Bottom Line Net Income3.1B3.7B10.1B20.3B20.0B
Per Share
Basic EPS$41.27$49.19$135.42$268.16$259.63
Diluted EPS$41.27$259.59
Revenue Per Share$2,243.78$2,229.55$2,227.64$2,287.03$2,155.78
Shares
Basic Shares Outstanding74.3M74.3M74.3M75.8M77.1M
Diluted Shares Outstanding
Profitability Metrics
EBITDA22.3B31.5B30.7B31.0B
D&A7.4B6.6B4.9B4.4B
EBIT13.7B14.9B24.9B25.8B26.7B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026